Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes.

Metabolism: clinical and experimental·2026
Same author

The impact of the Lancet Commission definition of obesity on its prevalence and implications on long-term cardiovascular-kidney-metabolic outcomes in East Asians: Observational study of two community-based cohorts.

PLoS medicine·2026
Same author

GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.

Diabetes care·2026
Same author

Postgraduate Medical Journal, the early years.

Postgraduate medical journal·2025
Same author

Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation.

BMC medicine·2025
Same author

Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.

Journal of the American Heart Association·2025

Related Experiment Videos

The hypertension-diabetes continuum.

Bernard M Y Cheung1

  • 1Department of Medicine, University of Hong Kong, Hong Kong. mycheung@hku.hk

Journal of Cardiovascular Pharmacology
|April 28, 2010
PubMed
Summary
This summary is machine-generated.

Hypertension and type 2 diabetes often coexist due to shared risk factors like obesity. Early identification and public health approaches targeting metabolic syndrome are crucial for managing these prevalent chronic conditions.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Hypertension and type 2 diabetes are common chronic conditions with significant overlap.
  • Shared genetic and environmental factors contribute to their co-occurrence, with obesity and physical inactivity being leading environmental causes.
  • Abdominal obesity can lead to lipid abnormalities, elevated blood pressure, and glucose levels, progressing to hypertension and diabetes.

Purpose of the Study:

  • To highlight the shared etiology and substantial overlap between hypertension and type 2 diabetes.
  • To emphasize the role of obesity and metabolic syndrome as key contributors to these conditions.
  • To advocate for a public health approach to address the rising prevalence of obesity and metabolic syndrome.

Main Methods:

  • Review of existing literature on the shared risk factors of hypertension and type 2 diabetes.
  • Analysis of data from the Hong Kong Cardiovascular Risk Factor Prevalence Study.
  • Examination of the components and implications of metabolic syndrome.

Main Results:

  • 40% of the community subjects had either raised blood pressure or raised blood glucose.
  • Only 42% of individuals with diabetes had normal blood pressure, and 56% with hypertension had normal glucose tolerance.
  • Obesity, lipid abnormalities, elevated blood pressure, and glucose are key components of metabolic syndrome.

Conclusions:

  • The co-existence of hypertension and diabetes necessitates clinical awareness of the potential presence of the other condition.
  • Metabolic syndrome represents a pathological process that may be reversible in its early stages.
  • Focusing on obesity and metabolic syndrome through public health initiatives is essential, given the increasing prevalence and limitations of pharmacologic approaches alone.